Hepion Pharmaceuticals, Inc. — Form D

Hepion Pharmaceuticals, Inc. of RED BANK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-03. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Robert FosterDirectorWaverly, OH
Gary S JacobDirectorNew York, NY
Anand ReddiDirectorEdison, NJ
Petrus P WijngaardDirectorEdison, NJ
Robert FosterExecutive OfficerWaverly, OH
Sireesh AppajosyulaRelated PersonRed Bank, NJ
Gary StetzRelated PersonRed Bank, NJ
Vincent LoPrioreRelated PersonRed Bank, NJ
James SapirsteinDirectorCincinnati, OH
James SapirsteinExecutive OfficerCincinnati, OH
Kaouthar P LbiatiDirectorEdison, NJ
John CavanExecutive OfficerEdison, NJ
Michael P PurcellDirectorEdison, NJ
Timothy P BlockDirectorEdison, NJ
Gary S JacobsDirectorEdison, NJ
Arnold P LippaDirectorEdison, NJ
Todd HobbsExecutive OfficerEdison, NJ
Gary JacobDirectorSan Diego, CA
John BrancaccioDirectorSan Diego, CA
Thomas P AdamsDirectorEdison, NJ
John P CavanExecutive OfficerEdison, NJ
John P BrancaccioDirectorNew Hope, PA
Bill HornungExecutive OfficerEdison, NJ
Timothy BlockDirectorRed Bank, NJ
Timothy BlockRelated PersonRed Bank, NJ

Other filings by this issuer (8)

FiledFormOfferingSold
2026-08-05D$3.1M$3.1M
2026-04-22D$700K$700K
2024-07-24D$2.9M$2.9M
2022-11-15D$20.0M$20.0M
2019-03-27D$1.3M$1.3M
2014-10-23D$12.5M$9.0M
2014-08-22D$4.7M$4.7M
2014-02-14D$3.2M$3.2M

More